Apellis Pharmaceuticals

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell APLS and other ETFs, options, and stocks.

About APLS

Apellis Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which develops novel therapeutic and complement immunotherapies for the treatment of complement-dependent autoimmune and inflammatory diseases through APL-2 product. The company was founded by Candace Rose Depp, Pascal Deschatelets, Cedric Francois, Alec Machiels on September 25, 2009 and is headquartered in Waltham, MA.

CEO

Cedric Francois

CEOCedric Francois

Employees

476

Employees476

Headquarters

Waltham, Massachusetts

HeadquartersWaltham, Massachusetts

Founded

2009

Founded2009

Employees

476

Employees476

APLS Key Statistics

Market cap

6.70B

Market cap6.70B

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

1.64M

Average volume1.64M

High today

$68.00

High today$68.00

Low today

$58.46

Low today$58.46

Open price

$68.00

Open price$68.00

Volume

4.86M

Volume4.86M

52 Week high

$70.00

52 Week high$70.00

52 Week low

$30.17

52 Week low$30.17

Analyst ratings

83%

of 18 ratings

Buy

83.3%

Hold

11.1%

Sell

5.6%

APLS Earnings

-$2.72

-$1.81

-$0.91

$0.00

Q1 FY21

Q2 FY21

Q3 FY21

Q4 FY21

Q1 FY22

Q2 FY22

Q3 FY22

Estimated

— per share

Estimated— per share

Actual

Expected Nov 7, After Hours

ActualExpected Nov 7, After Hours